Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00087425 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: bryostatin 1

Sponsor

National Institute on Aging (NIA)

Collaborators

[object Object]